Synopsys, Inc. $SNPS Shares Bought by Healthcare of Ontario Pension Plan Trust Fund

Healthcare of Ontario Pension Plan Trust Fund boosted its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 6.1% in the fourth quarter, HoldingsChannel.com reports. The fund owned 64,227 shares of the semiconductor company’s stock after acquiring an additional 3,713 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Synopsys were worth $30,169,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in SNPS. Brighton Jones LLC lifted its position in Synopsys by 5.7% during the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock worth $447,000 after acquiring an additional 50 shares during the period. Integrated Wealth Concepts LLC boosted its stake in shares of Synopsys by 11.6% in the first quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company’s stock worth $326,000 after buying an additional 79 shares during the last quarter. NewEdge Advisors LLC boosted its stake in shares of Synopsys by 15.1% in the first quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company’s stock worth $1,291,000 after buying an additional 395 shares during the last quarter. WINTON GROUP Ltd boosted its stake in shares of Synopsys by 9.2% in the second quarter. WINTON GROUP Ltd now owns 758 shares of the semiconductor company’s stock worth $389,000 after buying an additional 64 shares during the last quarter. Finally, Treasurer of the State of North Carolina boosted its stake in shares of Synopsys by 2.1% in the second quarter. Treasurer of the State of North Carolina now owns 72,095 shares of the semiconductor company’s stock worth $36,962,000 after buying an additional 1,505 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on SNPS. The Goldman Sachs Group set a $600.00 target price on Synopsys and gave the stock a “buy” rating in a research note on Wednesday, February 25th. Piper Sandler upped their target price on Synopsys from $430.00 to $450.00 and gave the stock a “neutral” rating in a research note on Thursday, May 28th. Bank of America upped their target price on Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. BNP Paribas Exane upped their target price on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research note on Thursday, May 28th. Finally, Citigroup upped their target price on Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Nine equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $563.81.

Insiders Place Their Bets

In related news, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.56% of the company’s stock.

Synopsys Stock Performance

NASDAQ SNPS opened at $454.38 on Tuesday. The stock has a market capitalization of $87.00 billion, a price-to-earnings ratio of 105.18, a PEG ratio of 2.67 and a beta of 1.22. Synopsys, Inc. has a twelve month low of $376.18 and a twelve month high of $651.73. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. The stock has a 50-day moving average of $474.73 and a 200 day moving average of $461.19.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The company had revenue of $2.28 billion during the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys’s quarterly revenue was up 41.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Sell-side analysts anticipate that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.